ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 0578 • ACR Convergence 2020

    Going Digital Due to COVID 19 Crisis: A Rapid Reorganisation of Medication Clinics

    Rian Penford1, Angela Reith1, Elaine Wren1 and Kirsten Mackay1, 1Torbay and South Devon NHS Foundation Trust, Torquay, United Kingdom

    Background/Purpose: Until the COVID 19 crisis we initiated DMARD(s) and Biologic therapies using shared medical clinics. More than 30 patients could seen per week, with…
  • Abstract Number: 0592 • ACR Convergence 2020

    A Rheumatology-Driven Protocol and Treatment Algorithm of SARS-CoV-2 Cytokine Release Syndrome and Its Associated Outcomes

    Sandy Lee1, Neha Chiruvolu2, Muntarin Karim3, Patil Injean4, Loomee Doo5, Donna Jose6, Deepa Panikkath1, Micah Yu5, Anna Lafian5, Wendy De La Pena7, Albert Chow8, Karina Torralba9, Vaneet Sandhu10, Mehrnaz Hojjati5, Marven Cabling5 and Christina Downey1, 1Loma Linda University Medical Center, Redlands, CA, 2UC Riverside School of Medicine, Riverside, CA, 3Loma Linda University Health System, Loma Linda, CA, 4LOMA LINDA UNIVERSITY MEDICAL CENTER - RHEUMATOLOGY, Redlands, CA, 5Loma Linda University Medical Center, LOMA LINDA, CA, 6Loma Linda University Medical Center, Ontario, CA, 7PRCSG, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 8Loma Linda University, San Bernardino, CA, 9Loma Linda University School of Medicine, Redlands, CA, 10Loma Linda University, Loma Linda, CA

    Background/Purpose: The newly identified SARS-CoV-2 has brought Cytokine Release Syndrome (CRS) to a level of prominence not often seen in adult medicine. Mortality rates of…
  • Abstract Number: 0591 • ACR Convergence 2020

    Intervention to Improve SLE Medication Adherence Using Surescripts Pharmacy Refill Data

    Kai Sun1, Jennifer Rogers2, Rebecca Sadun3, Amanda Eudy3, Jayanth Doss3, Lisa Criscione-Schreiber4, Ann Cameron Barr5, Lena Eder6, Mithu Maheswaranathan3, Amy Corneli7, Hayden Bosworth1 and Megan Clowse8, 1Duke University Hospital, Durham, 2Duke University Hospital, Durham, DE, 3Duke University, Durham, NC, 4Division of Rheumatology and Clinical Immunology, Department of Medicine, Duke University Medical Center, Durham, NC, 5Duke University Hospital, Durham, NC, 6Duke University Hospital, Chapel Hill, NC, 7Duke University, Durham, 8Duke University, Chapel Hill, NC

    Background/Purpose: Medication nonadherence is as high as 80% among SLE patients and leads to higher morbidity, mortality, and healthcare costs. Few studies have tested interventions…
  • Abstract Number: 0597 • ACR Convergence 2020

    Telemedicine in Pediatric Rheumatology During COVID-19: The PR-COIN Experience

    Y. Ingrid Goh1, Nancy Pan2, Julia Harris3, Andrew Warmin4, Janalee Taylor4, Sheetal Vora5, Fatima Barbar-Smiley6, Jon Burnham7, Tzielan Lee8, Cagri Yildirim-Toruner9, Kendra Wiegand10 and Esi Morgan11, 1The Hospital for Sick Children, Toronto, ON, Canada, 2Hospital for Special Surgery, New York, NY, 3Children's Mercy Kansas City, Overland Park, KS, 4Cincinnati Children's Hospital, Cincinnati, OH, 5Atrium Health Levine Children's Hospital, Charlotte, NC, 6Nationwide Children's Hospital/The Ohio State University, Columbus, OH, 7Children's Hospital of Philadelphia, Philadelphia, PA, 8Stanford University School of Medicine, Palo Alto, CA, 9Nationwide Children's Hospital, Houston, TX, 10Cincinnati Children's Hospital, Cincinnati, 11Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

    Background/Purpose: Healthcare teams were forced to rethink the way they practiced medicine during the COVID-19 pandemic. Many teams transitioned from conducting in-person visits to virtual…
  • Abstract Number: 0596 • ACR Convergence 2020

    Clinical Academic Rheumatology: A Boon for Health Systems

    Kathleena D'Anna1, Karina Torralba2, Christina Downey3 and Carlos Silva Lynch4, 1Loma Linda University Medical Center, Moreno Valley, CA, 2Loma Linda University School of Medicine, Redlands, CA, 3Loma Linda University Medical Center, Redlands, CA, 4Loma Linda University Medical Center, Loma Linda

    Background/Purpose: Finding a balance between clinical and scholarly productivity is a challenge for many academic clinician-educator (CE) rheumatologists. An examination of workload and practice-generated downstream…
  • Abstract Number: 0602 • ACR Convergence 2020

    Labor Impact of SARS-COV-2 Pandemic in Argentine Rheumatologists

    Scarafia Santiago1, Emilio Buschiazzo2, María Victoria Martire3, César Graf4 and Rodrigo Garcia Salinas5, 1Hospital Municipal "San Cayetano", Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina, 2Hospital Señor del Milagro, Salta., Salta, Salta, Argentina, 3Instituto Médico Platense, La Plata, La Plata, Buenos Aires, Argentina, 4Sociedad Argentina de Reumatología, Paraná, Entre Rios, Argentina, 5Hospital Italiano La Plata, La Plata, Argentina

    Background/Purpose: The novel coronavirus SARS2-COV-2 has precipitated the present outbreak of COVID-19, the worldwide spread has strong impact on general population and on healthcare workers.…
  • Abstract Number: 0604 • ACR Convergence 2020

    Increasing the Rate of Pneumococcal Vaccination in an Academic Rheumatology Outpatient Clinic

    Maria Bacalao1, Swathi Reddy2 and Nilofar Syed3, 1UT Southwestern, Dallas, TX, 2Veterans Affairs North Texas Healthcare System / UT Southwestern Medical Center, Dallas, TX, 3UT Southwestern Medical Center, RICHARDSON, TX

    Background/Purpose: Many patients with rheumatic diseases are at increased risk of infection, including invasive pneumococcal infection, due to both disease-related abnormalities of the immune system as…
  • Abstract Number: 0599 • ACR Convergence 2020

    Evaluation of Telephone Consultations in Germany as an Additional Tool in Outpatient Rheumatology Clinics During the COVID-19 Pandemic

    Ulrich Drott1, Axel Braner1, Thomas Kollewe2, Harald Burkhardt3 and Florian Meier1, 1Department of Rheumatology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany, Frankfurt, Germany, 2J. W. Goethe-Universität Frankfurt, FB Medizin, Frankfurter Arbeitsstelle für Medizindidaktik, Frankfurt, Germany, Frankfurt, Germany, 3Department of Rheumatology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany, Frankfurt am Main, Germany

    Background/Purpose: The Covid-19 pandemic holds multiple challenges for the healthcare system. Quick adoptions and adjustments are the mainstays during these times. Hygiene management and plans…
  • Abstract Number: 0594 • ACR Convergence 2020

    Mechanical and Temperature Stress During Biologic Shipments to Rheumatology Patients

    Sarah Dill1, Elizabeth Cheng2, Kyle Brees2, John Carpenter3 and Liron Caplan2, 1University of Colorado, Denver, CO, 2Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, CO, 3University of Colorado Skaggs School of Pharmacy, Aurora, CO

    Background/Purpose: Biologic medications are expensive, and unfortunately their immunogenicity contributes to loss of efficacy over time. Protein particles may form as a result of medication…
  • Abstract Number: 0607 • ACR Convergence 2020

    The Evolution of Rheumatologist’s Practice in Response to the COVID19 Pandemic

    Maria Bacalao1, Kathryn Dao2 and John Cush2, 1UT Southwestern, Dallas, TX, 2University of Texas Southwestern Medical School, Dallas, TX

    Background/Purpose: The COVID19 pandemic was a turning point for Rheumatology. This survey of rheumatologists (rheums) assessed its impact on care delivery, patient counseling and drug…
  • Abstract Number: 0610 • ACR Convergence 2020

    Change in Utilization of Outpatient Services at US Community Rheumatology Practices During COVID-19 Outbreak

    Kent Kwas Huston1, Nehad Soloman2, Janna Radtchenko3, Simon Helfgott4, Jasvinder Singh5 and Colin Edgerton6, 1Kansas City Physician Partners, Kansas City, MO, 2Arizona Arthritis & Rheumatology Associates, P.C., Peoria, AZ, 3Trio Health, Louisville, CO, 4BWH- HMS, Boston, MA, 5University of Alabama at Birmingham, Birmingham, AL, 6Articularis Healthcare, Summerville, SC

    Background/Purpose: Patients (pts) with autoimmune diseases managed by rheumatologists represent vulnerable population with risk of serious complications if exposed to novel coronavirus SARS-CoV2. The first…
  • Abstract Number: 0611 • ACR Convergence 2020

    Disease Activity and Disability Are Not Associated with Rehabilitation Utilization in African Americans with Rheumatoid Arthritis

    Louise Thoma1, Rebecca Cleveland2, S. Louis Bridges3, Beth Jonas1 and Leigh Callahan4, 1University of North Carolina at Chapel Hill, Chapel Hill, NC, 2University of North Carolina, Chapel Hill, NC, 3University of Alabama at Birmingham, Mountain Brk, AL, 4University of North Carolina Thurston Arthritis Research Center, Chapel Hill, NC

    Background/Purpose: Considerable advances in pharmacological care for adults with rheumatoid arthritis (RA) over the last 25 years have reduced disease activity in individual patients, but…
  • Abstract Number: 0606 • ACR Convergence 2020

    A Systematic Review Exploring Pre-COVID-19 Telehealthcare Models Used in the Management of Patients with Rheumatological Disease

    Alexandra Nelson1 and Marina Anderson2, 1University of Liverpool, Liverpool, United Kingdom, 2Lancaster University, Lancaster, United Kingdom

    Background/Purpose: Recent advancements in the delivery and utilization of information and communication technologies (ICTs) have led to an increased application of telehealthcare services. Global coronavirus…
  • Abstract Number: 0614 • ACR Convergence 2020

    Impact of COVID-19 Pandemic on the Rheumatology Practice in Mexico: Mexican College of Rheumatology Survey

    Natllely Ruiz1, José Enrique Ruiz Guizar2, Erick A Zamora Tehozol3, Iris Jazmín Colunga Pedraza4, Cristina Hernández-Díaz5, Vijaya Rivera-Terán6, Cesar Pacheco Tena7 and Deshire Alpizar-Rodriguez6, 1Instituto Nacional de Enfermedades Respiratorias, Mexico City, Distrito Federal, Mexico, 2Independent, Mexico City, Distrito Federal, Mexico, 3Centro Médico Pensiones, Merida, Yucatan, Mexico, 4Rheumatology service, Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma Nuevo León, Monterrey, Mexico, 5Instituto Nacional de Rehabilitación, Mexico City, Distrito Federal, Mexico, 6Colegio Mexicano de Reumatología, Mexico City, Distrito Federal, Mexico, 7Universidad Autonoma de Chihuahua, Chihuahua, Chihuahua, Mexico

    Background/Purpose: COVID-19 pandemic is an evident challenge for healthcare systems and daily clinical practice in developing countries. Particularly, chronic diseases attention has faced difficulties. The…
  • Abstract Number: 0609 • ACR Convergence 2020

    Impact of Depressive Symptoms, Anti-depression Treatment on Direct Medical Costs Among Medicare Beneficiaries with Knee Osteoarthritis (KOA)

    Shuang Song1, Jeffrey Katz2 and Elena Losina2, 1Brigham and Women's Hospital, Brighton, MA, 2Harvard Medical School / The Orthopaedic and Arthritis Center for Outcomes Research (OrACORe) at Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Depressive symptoms are prevalent among knee OA (KOA) patients and likely lead to additional medical costs. We sought to quantify the prevalence of depressive…
  • « Previous Page
  • 1
  • …
  • 665
  • 666
  • 667
  • 668
  • 669
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology